Sotrovimab for Mild to Moderate COVID-19, Myocardial Infarction After Hepatitis B Vaccine, Review of Antiseizure Medications for Epilepsy, and more

Published: April 5, 2022, 3 p.m.

Editor\u2019s Summary by Christopher Muth, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the April 5, 2022 issue.